Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases.
Arnaud PommierNaishitha AnaparthyNicoletta MemosZ Larkin KelleyAlizée GouronnecRan YanCédric AuffrayJean AlbrenguesMikala EgebladChristine A Iacobuzio-DonahueScott K LyonsDouglas T FearonPublished in: Science (New York, N.Y.) (2018)
The majority of patients with pancreatic ductal adenocarcinoma (PDA) develop metastatic disease after resection of their primary tumor. We found that livers from patients and mice with PDA harbor single disseminated cancer cells (DCCs) lacking expression of cytokeratin 19 (CK19) and major histocompatibility complex class I (MHCI). We created a mouse model to determine how these DCCs develop. Intraportal injection of immunogenic PDA cells into preimmunized mice seeded livers only with single, nonreplicating DCCs that were CK19- and MHCI- The DCCs exhibited an endoplasmic reticulum (ER) stress response but paradoxically lacked both inositol-requiring enzyme 1α activation and expression of the spliced form of transcription factor XBP1 (XBP1s). Inducible expression of XBP1s in DCCs, in combination with T cell depletion, stimulated the outgrowth of macrometastatic lesions that expressed CK19 and MHCI. Thus, unresolved ER stress enables DCCs to escape immunity and establish latent metastases.
Keyphrases
- endoplasmic reticulum stress
- induced apoptosis
- poor prognosis
- endoplasmic reticulum
- mouse model
- transcription factor
- end stage renal disease
- protein kinase
- squamous cell carcinoma
- small cell lung cancer
- chronic kidney disease
- binding protein
- high fat diet induced
- newly diagnosed
- signaling pathway
- cell proliferation
- prognostic factors
- adipose tissue
- metabolic syndrome
- breast cancer cells
- insulin resistance
- patient reported